Show simple item record

Evaluation of the clinical utility of urocortin 1 in systolic heart failure

dc.contributor.authorCakmak, Huseyin Altug
dc.contributor.authorYildirim, Erkan
dc.contributor.authorCosansu, Kahraman
dc.contributor.authorIkitimur, Barış
dc.contributor.authorCan, Gunay
dc.contributor.authorKeles, Ibrahim
dc.date.accessioned2021-03-05T17:37:24Z
dc.date.available2021-03-05T17:37:24Z
dc.date.issued2014
dc.identifier.citationYildirim E., Keles I., Cakmak H. A. , Cosansu K., Can G., Ikitimur B., "Evaluation of the clinical utility of urocortin 1 in systolic heart failure", KARDIOLOGIA POLSKA, cilt.72, ss.452-458, 2014
dc.identifier.issn0022-9032
dc.identifier.otherav_c672d275-be1e-4e9b-aa86-b13bd56f5e5d
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/131573
dc.identifier.urihttps://doi.org/10.5603/kp.a2013.0353
dc.description.abstractBackground: Urocortin 1 (UCN1) has cardiostimulatory, vasodilatory, diuretic and natriuretic effects, and its expression increases in heart failure (HF). Aim: To determine UCN1 levels in patients with HF, to evaluate UCN1's relationship with various clinical parameters, and to assess UCN1 as a diagnostic marker in HF, compared to pro-B-type natriuretic peptide (pro-BNP).
dc.language.isoeng
dc.subjectKardiyoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.titleEvaluation of the clinical utility of urocortin 1 in systolic heart failure
dc.typeMakale
dc.relation.journalKARDIOLOGIA POLSKA
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume72
dc.identifier.issue5
dc.identifier.startpage452
dc.identifier.endpage458
dc.contributor.firstauthorID89645


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record